News & events

• Latest news
  • News archive
  • Fighting for a vaccine in memory of Kayden
  • Meningitis strikes Mossley family twice
  • Motocross in memory of Kelsey
  • Survivor Louise launches Big Stroll at Giants Causeway
  • Running in memory of Ross
  • Brave parents raise awareness in memory of Kadyn
  • Friends and family unite to remember Joél
  • Pounding the pavements in memory of Hannah
  • Meningitis survivor takes on personal swimming challenge
  • Raising awareness of meningitis in memory of Samantha
  • Runners unite for World Meningitis Day
  • Torch bearer Sally swims for the fight against meningitis
  • Take part in the Great North Run
  • Walking in memory of Stuart
  • Families step out for Big Stroll North East
  • Pub punters help stamp out meningitis
  • Meningitis UK welcomes Meningitis B vaccine trial news
  • Families touched by meningitis help launch awareness trailer
  • Motocross fundraiser in Kelsey Smart's memory raises £900
  • Pop starlet Pixie ready for charity jubilee concert
  • Team of cyclists taking on Pembrokeshire Charity Bike Ride in Hannah Gwilliam's memory
• Photo gallery
• Video
• Media centre
• Newsletter
• Supporter DVD
• 10th Anniversary
• Information days
• Search 4 a Vaccine Campaign

News RSS Feed

Standing ovation for Steve

04.03.10 

MENINGITIS UK Chief Executive Steve Dayman has opened a global conference for pharmaceutical company Novartis.

Around 120 staff from Novartis greeted Steve with a standing ovation after he recounted how he's dedicated his life to finding a vaccine for the deadly disease which took his son Spencer's life in 1982.

The conference was for Novartis' marketing, commercial, medical and policy associates, with the theme of Inspiring Marketing and Market Access.

Steve described the profound impact meningitis can have on a person's life and how such an experience changes one's understanding of public health.

He highlighted how the introduction of vaccines in the past 20 years has helped to improve public health.

But the biggest challenge still remains - finding a vaccine for meningococcal disease.